Combined application of anti-tumor antibiotic doxorubicin and inhibitor MTOR - rapamicine restores the sensitivity of leukemia cells ТНР-1 infected with human cytomogalovirus and
- Authors: Chernorizh Y.Y.1, Fedorova N.E1, Yurlov K.I1, Ivanov A.V2, Kushch A.A1
-
Affiliations:
- Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
- Engelhardt Institute of Molecular Biology RAS
- Issue: Vol 14, No 3 (2019)
- Pages: 70-71
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122329
- DOI: https://doi.org/10.23868/gc122329
- ID: 122329
Cite item
Abstract
Full Text
About the authors
Ya. Yu Chernorizh
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
Email: Revengeful_w@mail.ru
Moscow, Russia
N. E Fedorova
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
K. I Yurlov
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
A. V Ivanov
Engelhardt Institute of Molecular Biology RASMoscow, Russia
A. A Kushch
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia